Invacare stock: buy or sell?
November 15th, 2019
Invacare Corporation, together with its subsidiaries, designs, manufactures, distributes, and exports medical equipment for use in home health care, retail, and extended care markets worldwide.
Should I buy Invacare stock?You can't be a successful trader if you don't follow a methodolgy or system that assist you in choosing companies and the correct market timing. That's why is so important to choose your own trading strategy that matches with your character as inversor. There are thousands of trading strategies for you to choose, but at Stocks2.com we prefer those that are simple but successful.
Currently, Invacare stock doesn't match any of these trading strategies, so our recommendation is not to buy.
|New all-time high||No|
|New 52 week high||No|
|Price crossing up 200d MA||No|
|100d MA crossing up 200d MA||No|
Is Invacare stock a buy?
Financial institutions and banks post stock ratings everyday.At Stocks2.com, we found 1 rating published for IVC stock in the last month.
|Date||Analyst / Broker||Previous rating||Current rating|
|2019-2-14||Needham & Company LLC||n/a||Buy|
Invacare stock analysis
Shares of Invacare ended yesterday at $10.43 and boosted an outstanding 4.09%.
Invacare shares boosted 4.09% to $10.43 yesterday. For the last 24 days when IVC stock price broke up the SMA200d line, it gained $4.41 (73.26%). On September, SMA50d and SMA100d crossed up triggering a rise of 44.26%.
After boosting an astounding 24.02% in a week last week, Invacare closed this week at $10.43 and eased a fateful -2.52%. By mid October IVC plummed a bloodcurdling -13.29% in just one week.
In a weekly time frame, Invacare stock is drawing an uptrend with rising tops and bottoms. Now trading in between its last bottom and last top, IVC might consolidate in a flat-base, waiting to break out over or down under . Since late October when IVC stock price broke up the SMA40w line, it gained $4.26 (69.04%). Since SMA10d and SMA20w crossed up late September, IVC price climbed $2.56 per share (32.53%).
Invacare stock price history
Invacare IPO was on May 11th, 1984 at $0.00 per share1. Since then, IVC stock surged a inf%, with a yearly average of inf%. If you had invested right after IVC's IPO a $1,000 in Invacare stock in 1984, it would worth $inf today.
1: Adjusted price after possible price splits or reverse-splits.
Invacare stock historical price chart
IVC stock reached 52-week highs on Nov/7 at $11.63, and all-time highs 2004-12-13 with a price of 49.88.
Invacare stock price target is $15.00Nobody can reliably foresee how stock prices may evolve in the future. However, financial institutions invest time and resources to provide the most accurated estimations to help investors to make their decisions. The accuracy of these stock price predictions is not very high, and you should not blindly believe and make decisions only based on what this ratings or price target predictions say. For the last month we only found 1 price target for Invacare stock:
|Date||Analyst / Broker||Action||Previous target||Current target||Diff|
|2019-2-14||Needham & Company LLC||Reiterates||n/a||$15.00||-|
Financials and fundamental analysis
Earnings date and Earnings per ShareInvacare failed experts on February when it posted an Earnings per Share (EPS) of $-0.16 when the analysts' forecast was $-0.39.
|Quarter||Reporting date||Estimated EPS||Actual EPS||Surprise|
Annual financial resultsCompared to 2017, last anual turnover report draw a slightly fine movement of 0.61% to $972.35 M dollars. When comparing 2018 vs 2017, on the other hand, profit margin (that is, the net income divided by revenues) inched a 3.40% to -4.52%.
|2013||$1,350 M||-||$-51.00 M-3.8%||-|
|2014||$1,270 M||-5.91%||$-56.07 M-4.4%||9.94%|
|2015||$1,142 M||-10.06%||$-26.19 M-2.3%||-53.29%|
|2016||$1,047 M||-8.30%||$-42.86 M-4.1%||63.63%|
|2017||$966 M||-7.73%||$-76.54 M-7.9%||78.60%|
|2018||$972 M||0.61%||$-43.92 M-4.5%||-42.62%|
Quarterly financial resultsInvacare posted $244.58 M in sales for 2018-Q4, a 0.01% improvement compared to previous quarter. Reported quarter income marked $-1.25 million with a profit margin of -0.51%. Profit margin grew a 4.41% compared to previous quarter when profit margin was -4.92%. When comparing turnover to same quarter last year, Invacare sales marked a bad correction and decreased a -2.31%.
|2017-Q1||$232 M||-||$-16.78 M-7.2%||-|
|2017-Q2||$234 M||0.87%||$-23.51 M-10.1%||40.11%|
|2017-Q3||$251 M||7.37%||$-18.59 M-7.4%||-20.92%|
|2017-Q4||$250 M||-0.22%||$-17.66 M-7.1%||-5.00%|
|2018-Q1||$237 M||-5.31%||$-14.11 M-6.0%||-20.12%|
|2018-Q2||$246 M||3.84%||$-16.54 M-6.7%||17.26%|
|2018-Q3||$245 M||-0.65%||$-12.03 M-4.9%||-27.30%|
|2018-Q4||$245 M||0.01%||$-1.25 M-0.5%||-89.65%|
Invacare ownershipWhen you are planning to buy a stock, it's worth to overview its ownership structure.
Management staff in all public traded companies that hold equity is required to report every transaction to the SEC. For Invacare, 3.46% of all outstanding shares are owned by its staff.
Bearish positions for IVC stock account 0.00%, no big difference from last month.
The following table compares ownership indicators for other stocks related to Invacare:
|Market cap||$351.0 M||$3.9 M||$7.0 B||$1.6 B||$418.0 M|
|Total shares||33.7 M||4.0 M||66.8 M||22.0 M||62.9 M|
|Float shares||31.2 M||2.2 M||67.4 M||18.2 M||60.3 M|
|- Institutional holdings (%)||124.2%||11.2%||86.3%||109.7%||98.2%|
|- Insider holdings (%)||3.5%||62.9%||0.1%||1.2%||3.5%|
|Shares in short selling||0.0%||0.0%||0.0%||0.0%||0.0%|
|Friday, November 15th, 2019|
|Day range||$10.10 - $10.54|
|Average true range||$0.98|
|50d mov avg||$7.58|
|100d mov avg||$6.29|
|200d mov avg||$6.78|
Invacare performancePerformance as an absolute value is never valid if it's not benchmarked against competitors or related stocks in the industry. For Invacare, the benchmark is made against Allied Healthcare Products, Hill-Rom, Inogen, Owens & Minor, Sonoma Pharmaceuticals, Stryker and Teleflex.
|OMIOwens & Minor||36.83%||85.24%||-21.58%|